Emcure Pharma’s SAKHI – Diabetes awareness program makes to Asia Book of Records

Emcure Pharmaceuticals, a leading pharma company with a strong focus on women’s healthcare, achieved a significant milestone on World Diabetes Day, making it to the Asia Book of Records for orchestrating the largest virtual diabetes awareness campaign focused on women’s health.

The record-setting initiative brought together 20,000 healthcare professionals (HCPs) to create awareness and recommend essential lifestyle modifications for women managing diabetes.

Prevalence of diabetes in women (18 years and above) in India in 2022 is 23.7%. Studies estimate that approximately 8-10% of women in India have diabetes, though rates vary by region, age group, and urban versus rural setting. Urban areas often have a higher prevalence due to lifestyle factors, while rural areas show increasing rates as well.

The awareness campaign, unveiled at the prestigious 52nd Annual Conference of Research Society for the Study of Diabetes in India (RSSDI) in Delhi, introduces a comprehensive “9 Steps approach for diabetes management and prevention in women. This evidence-based framework, developed in collaboration with over 20,000 healthcare professionals, addresses the unique challenges faced by women with diabetes.

A “9-Steps” poster to reinforce the importance of effective lifestyle modification and management of diabetes was released during the RSSDI meeting in Delhi on November 15, 2024. In addition, the official Asia Book of Records ceremony recognizing this noteworthy accomplishment took place during this occasion.

The campaign, part of Emcure’s “SAKHI” initiative, demonstrates the company’s commitment to improving women’s health through innovative approaches to disease management and prevention.